Literature DB >> 18161711

FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.

Rachel Morra, Pascal Lebray, Patrick Ingiliz, Yen Ngo, Mona Munteanu, Vlad Ratziu, Thierry Poynard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18161711     DOI： 10.1002/hep.22046

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

Review 1.  Non-invasive assessment of liver fibrosis in chronic hepatitis B.

Authors:  Federica Branchi; Clara Benedetta Conti; Alessandra Baccarin; Pietro Lampertico; Dario Conte; Mirella Fraquelli
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 2.  Non-invasive diagnosis of hepatitis B virus-related cirrhosis.

Authors:  Sangheun Lee; Do Young Kim
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 3.  Non-invasive prediction of forthcoming cirrhosis-related complications.

Authors:  Wonseok Kang; Seung Up Kim; Sang Hoon Ahn
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

4.  Is aspartate aminotransferase-to-platelet ratio index a biomarker in the evaluation of advanced fibrosis in non-alcoholic fatty liver disease?

Authors:  Mehmet Agilli; Fevzi Nuri Aydin; Tuncer Cayci; Yasemin Gulcan Kurt
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.